Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
CASE REPORT
Year : 2010  |  Volume : 6  |  Issue : 3  |  Page : 353-355

Bilateral renal metastases in a case of Merkel cell carcinoma


1 Department of Radiodiagnosis, Tata Memorial Hospital, Mumbai - 12, India
2 Department of Bio-Imaging Unit, Tata Memorial Hospital, Mumbai - 12, India
3 Department of Pathology, Tata Memorial Hospital, Mumbai - 12, India

Date of Web Publication29-Nov-2010

Correspondence Address:
Sumeet G Dua
Bio-Imaging Unit, Tata Memorial Hospital, Mumbai - 12
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.73365

Rights and Permissions
 > Abstract 

Merkel cell carcinoma is a primary neuroendocrine carcinoma of the skin. It is a highly aggressive tumor which commonly metastasizes to lymph nodes, liver, lung and bone. The diagnosis is based on histology and immunohistochemistry. Renal metastasis, with sparing of other common sites of hematogenous spread (lung and liver), is a unique feature of this case.

Keywords: Kidney/renal metastases, merkel cell carcinoma, skin tumor


How to cite this article:
Medhi S, Purandare NC, Dua SG, Gujral S. Bilateral renal metastases in a case of Merkel cell carcinoma. J Can Res Ther 2010;6:353-5

How to cite this URL:
Medhi S, Purandare NC, Dua SG, Gujral S. Bilateral renal metastases in a case of Merkel cell carcinoma. J Can Res Ther [serial online] 2010 [cited 2019 Sep 16];6:353-5. Available from: http://www.cancerjournal.net/text.asp?2010/6/3/353/73365


 > Introduction Top


Merkel cell carcinoma, by virtue of its inherent aggressiveness, often spreads to the draining nodes, with frequent metastatic dissemination to the lung, liver and bones. This report describes bilateral renal metastases from a Merkel cell carcinoma, never documented before with a note on the role of imaging in staging of Merkel cell cancer.


 > Case Report Top


A 64-year-old man presented with a skin nodule in the right thigh that had progressively increased in size over a period of three months. On clinical examination, this nodule was pink, painless and measured about 3 cm in diameter. The patient had no other symptoms and rest of the physical examination was normal. There was no inguinal adenopathy.

An excisional biopsy of the nodule was performed. Histopathology revealed round cell tumor with the cells arranged in nests, cords and trabeculae. The tumor cells showed stippled chromatin without nucleoli. High degree of mitosis and apoptosis was seen. Overlying skin was infiltrated by the tumor. On immunohistochemistry, the tumor cells showed dot like positivity for cytokeratin-20 (CK-20) and also expressed epithelial membrane antigen (epithelial markers) and neuron-specific enolase. Tumor cells were negative for S-100 protein and HMB45 (melanoma markers), chromogranin and synaptophysin (neural markers), Mic2, calponin and Bcl-2 (PNET and synovial sarcoma markers). A diagnosis of Merkel cell carcinoma was rendered.

A computed tomography (CT) scan of the thorax, abdomen and pelvis was performed to look for distant metastases. There were no lung nodules or liver metastases; however, multiple focal necrotic masses were noted in both kidneys [Figure 1]. The renal masses showed perinephric extension and heterogenous contrast enhancement with hypodense areas within, suggesting an aggressive pathology. The right sided renal mass showed infiltration of the right lobe of the liver.
Figure 1: Axial contrast enhanced CT image through the abdomen shows bilateral heterogeneously enhancing renal masses (arrows) showing central necrosis, suggestive of its aggressive nature

Click here to view


Ultrasound-guided fine needle aspiration of bilateral renal masses revealed a cellular round cell tumor [Figure 2] which was compatible with metastases from a known Merkel cell carcinoma of thigh.
Figure 2: Fine needle aspirate smear of the left kidney mass shows a cellular aspirate and showed a round cell tumor. The tumor cells were round (arrow), monomorphic with fine salt and peppery nuclear chromatin (Papanicolaou stain × oil immersion)

Click here to view


In view of metastatic disease, patient was offered palliative chemotherapy.


 > Discussion Top


Merkel cell carcinoma (MCC) is a rare, aggressive primary neuroendocrine carcinoma of the skin. It is also known as primary small cell carcinoma or trabecular cell carcinoma. In 1972, Toker described five cases of trabecular cell carcinoma of skin and attributed its origin to sweat glands. [1] However, in 1978, Tang and Toker, on electron microscopy discovered dense core granules characteristic of Merkel cells and other neuroendocrine cells, indicating an origin from the Merkel cell. [2] Merkel cell is a specialized mechanoreceptor situated in the basal cell layer of the epidermis. [3] The name Merkel cell carcinoma was suggested by De Wolf-Peeters et al, in 1980. [4]

Most cases of MCC are reported in the elderly, with a notable high incidence in subjects with AIDS or with a prior history of organ transplantation. [5] The classical clinical presentation is a rapidly expanding, 1-2 cm sized, asymptomatic, red/pink nodule seen on sun-exposed skin. The common sites of involvement are head, neck, lower and upper extremities. [6] Spread to the draining nodes is a frequent finding and is associated with a higher local recurrence following surgery. [7] Distant metastases are seen in about half of the cases particularly involving the lung, liver and bone and correlates with adverse prognosis. [8]

The diagnosis of MCC is based on histological and immunohistochemical analysis of biopsied tissue. The nodule is often localized to the dermis and can spread superficially or deep to involve the epidermis and subcutaneous tissues, respectively. Classical histological features include a triad of vesicular nuclei with tiny nucleoli, and numerous mitoses and apoptosis, with accompanying lymphovascular invasion. [9] MCC is categorized into a group of small blue cell tumors which includes other tumors such as small-cell lung cancer, lymphoma, neuroblastoma, Ewing's sarcoma, melanoma and basal-cell carcinoma. [8] The diagnosis is based on the characteristic dot-like positivity for CK-20 expressed by MCCs on immunohistochemistry, although neuroendocrine (neurone-specific enolase, synaptophysin, chromogranin) and other cytokeratin (CAM 5.2) markers are also expressed. [10]

Surgical excision is the mainstay of treatment, with adjuvant radiotherapy being offered to almost all patients. Chemotherapy is generally reserved for palliation of metastatic disease. [11]

Unusual sites of distant metastases from MCC described in literature include urinary bladder, [12] prostate [12] and pancreas. [13] An extensive review of literature revealed a solitary reference of renal metastases from MCC, [14] where the patient presented with renal metastasis two years after surgery and radiotherapy for the primary tumor in the sacral region emphasizing the rarity of this finding. However in our case, bilateral renal metastases were detected on CT scan during the initial staging workup. Moreover, there were no clinical signs or symptoms attributable to the renal masses. Bilateral renal masses as seen in our case could also have been bilateral renal cell carcinomas in a case of a multisystem disorder like von Hippel Lindau disease (VHL). Radiologically, these findingsth can be very similar and differentiation between metastases and primary renal carcinomas would be difficult. The more common features of VHL like pancreatic cyts, renal cysts were not seen. Clinical features due to cerebellar and retinal hemangioblastomas seen very often with VHL were also absent though no imaging of the brain was performed to rule out these conditions. In view of the known primary disease, an FNA cytology was attempted from the renal masses which revealed metastatic MCC.

The finding of bilateral renal masses with an aggressive appearance on imaging should always raise the possibility of secondary renal involvement particularly in a patient with a known malignancy, even though the primary (Merkel cell carcinoma in our case) may show a very low propensity of renal metastases.

The presentation of a patient of primary MCC with bilateral renal metastases without involvement of local nodes or other commonly encountered sites of distant metastases is a unique feature of this case. This report also brings to focus the value of imaging in unmasking the common as well as rare sites of metastases in uncommon tumors like MCC.

 
 > References Top

1.Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-10.   Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Tang CK, Toker C. Trabecular carcinoma of the skin: An ultrastructural study. Cancer 1978;42:2311-21.  Back to cited text no. 2
    
3.Winkelmann RK, Breathnach AS. The Merkel cell. J Invest Dermatol 1973;60:2-15.  Back to cited text no. 3
[PUBMED]    
4.De Wolf-Peeters C, Marien K, Mebis J, Desmet V. A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior. Cancer 1980;46:1810-6.  Back to cited text no. 4
    
5.Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet 2002;359:497-8.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Health M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peρas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features. J Am Acad Dermatol 2008;58:375-81.  Back to cited text no. 6
    
7.Gupta SG, Wang LC, Peρas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymphnode biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and analysis of the literature. Arch Dermatol 2006;142:685-90.  Back to cited text no. 7
    
8.Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593-9.  Back to cited text no. 8
[PUBMED]  [FULLTEXT]  
9.Haag M, Glass LF, Fenske NA. Merkel cell carcinoma: Diagnosis and treatment. Dermatol Surg 1995;21:669-83.  Back to cited text no. 9
    
10.Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588-98.  Back to cited text no. 10
[PUBMED]  [FULLTEXT]  
11.Zampetti A, Felicani C, Massi G, Tulli A. Updated review of the pathogenesis and management of merkel cell carcinoma. J Cutan Med Surg 2010;14:51-61.  Back to cited text no. 11
    
12.Mack DP, Moussa M, Cook A, Izawa JI. Metastatic merkel cell tumor to the prostate and bladder. Urology 2004;64:156-8.  Back to cited text no. 12
    
13.Ouellette JR, Woodyard L, Toth L, Termuhlen PM. Merkel cell carcinoma metastatic to the head of the pancreas. JOP 2004;5:92-6.  Back to cited text no. 13
[PUBMED]  [FULLTEXT]  
14.Pollheimer VS, Bodo K, Pollheimer MJ, Zigeuner R, Langner C. Merkel cell carcinoma metastasizing to the kidney mimicking primary neuroendocrine renal cancer. APMIS 2007;115:774-7.  Back to cited text no. 14
[PUBMED]  [FULLTEXT]  


    Figures

  [Figure 1], [Figure 2]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  >Abstract>Introduction>Case Report>Discussion>Article Figures
  In this article
>References

 Article Access Statistics
    Viewed2909    
    Printed159    
    Emailed0    
    PDF Downloaded201    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]